Search

Your search keyword '"The Lancet Gastroenterology Hepatology"' showing total 316 results
Start Over Author "The Lancet Gastroenterology Hepatology"
316 results on '"The Lancet Gastroenterology Hepatology"'

12. New restrictions on JAK inhibitors in the EU

Author

The Lancet Gastroenterology Hepatology

Subjects
Pyrimidines, Hepatology, Gastroenterology, Humans, Janus Kinase Inhibitors, Protein Kinase Inhibitors
Published
2023

15. Public health funding in England: death by a thousand cuts

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Financing, Government, Hepatology, England, SARS-CoV-2, Health Care Reform, Health Policy, Gastroenterology, COVID-19, Humans, Public Health, Mortality, Delivery of Health Care, State Medicine
Published
2021

16. Water and sanitation for all

Author

The Lancet Gastroenterology Hepatology

Subjects
Hepatology, Water Supply, Gastroenterology, Humans, Water, Public Health, Sanitation
Published
2022

17. Crunching the numbers for viral hepatitis

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Hepatology, Gastroenterology, Humans, Global Health, Antiviral Agents, Developing Countries, Hepatitis C, Drug Costs, Health Services Accessibility
Published
2021

19. The world is failing on hunger

Author

The Lancet Gastroenterology Hepatology

Subjects
Hepatology, Hunger, Gastroenterology, Humans, Global Health
Published
2022

25. Removing barriers to living organ donation

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Insurance, Health, Tissue and Organ Procurement, Hepatology, Gastroenterology, Living Donors, Humans, United States
Published
2021

26. Pancreatic cancer: a state of emergency?

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Europe, Pancreatic Neoplasms, Biomedical Research, Hepatology, Research Support as Topic, Gastroenterology, Humans, Emergencies, Global Health, Prognosis, Combined Modality Therapy, Early Detection of Cancer, Health Services Accessibility
Published
2021

28. Is the promise of probiotics being fulfilled?

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Biomedical Research, Evidence-Based Medicine, Hepatology, Gastrointestinal Diseases, Research Design, Probiotics, Practice Guidelines as Topic, Gastroenterology, Humans, Societies, Medical
Published
2020

30. Alcohol and health: time for an overdue conversation

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Adult, Male, Hepatology, Alcoholic Beverages, Liver Diseases, Gastroenterology, Awareness, Global Burden of Disease, Alcoholism, Risk Factors, Humans, Female, Alcohol-Related Disorders, Aged
Published
2020

31. Headway and hurdles in non-alcoholic fatty liver disease

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Adult, Young Adult, Hepatology, Adolescent, Non-alcoholic Fatty Liver Disease, Gastroenterology, Disease Progression, Disease Management, Humans, Morbidity, Child, Global Health
Published
2020

33. Improving liver cancer care across Europe

Author

The Lancet Gastroenterology Hepatology

Subjects
Europe, Hepatology, Liver Neoplasms, Gastroenterology, Humans, Healthcare Disparities, Health Services Accessibility
Published
2022

34. The lottery of primary care for liver disease

Author

The Lancet Gastroenterology Hepatology

Subjects
Adult, Hematologic Tests, Alcohol Drinking, Primary Health Care, Hepatology, Liver Diseases, Gastroenterology, Disease Management, Middle Aged, United Kingdom, Cost of Illness, Reward, Non-alcoholic Fatty Liver Disease, Evidence-Based Practice, Elasticity Imaging Techniques, Humans, Obesity, Morbidity
Published
2021

38. Alcohol-related harm during the COVID-19 pandemic

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Editorial, Hepatology, Alcohol Drinking, SARS-CoV-2, Incidence, Gastroenterology, COVID-19, Humans, Pandemics, United States
Published
2021

39. The great obesity debate: divided we fall

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Hepatology, Social Determinants of Health, Health Policy, Social Stigma, Gastroenterology, Disease Management, Standard of Care, Health Promotion, United Kingdom, Neoplasms, Humans, Obesity, Public Health, Empathy
Published
2019

40. Food safety really is everyone's business

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Foodborne Diseases, Food Safety, Internationality, Hepatology, Food Labeling, Gastroenterology, Humans, Legislation, Food
Published
2019

42. A watershed moment in tackling childhood obesity

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Internet, Pediatric Obesity, Hepatology, Advertising, Dietary Sucrose, Food, Gastroenterology, Humans, Public Policy, Television, Sodium Chloride, Dietary, Dietary Fats, United Kingdom
Published
2019

43. Pancreatic cancer screening: more harms than benefits?

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Pancreatic Neoplasms, Survival Rate, Hepatology, Risk Factors, Incidence, Preventive Health Services, Gastroenterology, Humans, Mass Screening, Awareness, Early Detection of Cancer, United States
Published
2019

44. Undiagnosed hepatitis in patients with cancer

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Hepatitis B virus, Hepatology, Drug Therapy, Neoplasms, Carrier State, Gastroenterology, Humans, Hepacivirus, Hepatitis B, Hepatitis C, United States
Published
2019

45. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

Author

Cooke, Graham S, Andrieux-Meyer, Isabelle, Applegate, Tanya L, Atun, Rifat, Burry, Jessica R, Cheinquer, Hugo, Dusheiko, Geoff, Feld, Jordan J, Gore, Charles, Griswold, Max G, Hamid, Saeed, Hellard, Margaret E, Hou, JinLin, Howell, Jess, Jia, Jidong, Kravchenko, Natalia, Lazarus, Jeffrey V, Lemoine, Maud, Lesi, Olufunmilayo A, Maistat, Liudmyla, McMahon, Brian J, Razavi, Homie, Roberts, Teri, Simmons, Bryony, Sonderup, Mark W, Spearman, C Wendy, Taylor, Bridie E, Thomas, David L, Waked, Imam, Ward, John W, Wiktor, Stefan Z, and Lancet Gastroenterology & Hepatology Commissioners

Abstract

Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV and tuberculosis. Highly effective prevention measures and treatments have made the global elimination of viral hepatitis a realistic goal, endorsed by all WHO member states. Ambitious targets call for a global reduction in hepatitis-related mortality of 65% and a 90% reduction in new infections by 2030. This Commission draws together a wide range of expertise to appraise the current global situation and to identify priorities globally, regionally, and nationally needed to accelerate progress. We identify 20 heavily burdened countries that account for over 75% of the global burden of viral hepatitis. Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020. In addition to further measures to improve access to vaccination and treatment, greater attention needs to be paid to access to affordable, high-quality diagnostics if testing is to reach the levels needed to achieve elimination goals. Simplified, decentralised models of care removing requirements for specialised prescribing will be required to reach those in need, together with sustained efforts to tackle stigma and discrimination. We identify key examples of the progress that has already been made in many countries throughout the world, demonstrating that sustained and coordinated efforts can be successful in achieving the WHO elimination goals.

Published
2019

46. Probiotics: elixir or empty promise?

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Gastrointestinal Tract, Clinical Trials as Topic, Hepatology, Lacticaseibacillus rhamnosus, Probiotics, North America, Gastroenterology, Humans, Fecal Microbiota Transplantation, Lactobacillus helveticus, Gastroenteritis, Gastrointestinal Microbiome
Published
2019

47. Drug pricing: still a barrier to elimination of HCV

Author

null The Lancet Gastroenterology & Hepatology

Subjects
Fluorenes, Hepatology, Gastroenterology, Hepatitis C, Chronic, Antiviral Agents, Heterocyclic Compounds, 4 or More Rings, Drug Costs, United States, Drug Combinations, Humans, Benzimidazoles, Carbamates, Disease Eradication, Sofosbuvir, Uridine Monophosphate
Published
2018

Catalog

Books, media, physical & digital resources
See catalog results